Publications of Verena Lohr

Lohr, V., Hädicke, O., Genzel, Y., Jordan, I., Buentemeyer, H., Klamt, S., & Reichl, U. (2014)The avian cell line AGE1.CR.pIX characterized by metabolic flux analysisBMC Biotechnology, 14, 72doi: 10.1186/1472-6750-14-72.

Hädicke, O., Lohr, V., Genzel, Y., Reichl, U., & Klamt, S. (2013)Evaluating differences of metabolic performances: Statistical methods and their application to animal cell cultivationsBiotechnology and Bioengineering, 110 (10), 2633–2642doi: 10.1002/bit.24926.

Jordan, I., Lohr, V., Genzel, Y., Reichl, U., & Sandig, V. (2013)Elements in the Development of a Production Process for Modified Vaccinia Virus AnkaraMicroorganisms, 1 (1), 100–121doi: 10.3390/microorganisms1010100.

Lohr, V., Genzel, Y., Jordan, I., Katinger, D., Mahr, S., Sandig, V., & Reichl, U. (2012)Live attenuated influenza viruses produced in a suspension process with avian AGE1.CR.pIX cellsBMC Biotechnology, 12, 79doi: 10.1186/1472-6750-12-79.

Petiot, E., Jacob, D., Lanthier, S., Lohr, V., Ansorge, S., & Kamen, A. A. (2011)Metabolic and Kinetic analyses of influenza production in perfusion HEK293 cell cultureBMC Biotechnology, 11 (84), 1–12doi: 10.1186/1472-6750-11-84.

Rödig, J., Rapp, E., Djeljadini, S., Lohr, V., Genzel, Y., Jordan, I., Sandig, V., & Reichl, U. (2011)Impact of Influenza Virus Adaptation Status on HA N-Glycosylation Patterns in Cell Culture-Based Vaccine ProductionJournal of Carbohydrate Chemistry, 30 (4-6), 281–290doi: 10.1080/07328303.2011.604454.

Lohr, V., Genzel, Y., Behrendt, I., Scharfenberg, K., & Reichl, U. (2010)A new MDCK suspension line cultivated in a fully defined medium in stirred-tank and wave bioreactorVaccine, 28 (38), 6256–6264doi: 10.1016/j.vaccine.2010.07.004.

Lohr, V., Rath, A., Genzel, Y., Jordan, I., Sandig, V., & Reichl, U. (2009)New avian suspension cell lines provide production of influenza virus and MVA in serum-free media: studies on growth, metabolism and virus propagationVaccine, 27 (36), 4975–4982doi: 10.1016/j.vaccine.2009.05.083.

Lohr, V., Rath, A., Jordan, I., Sandig, V., Genzel, Y., & Reichl, U. (2012)Avian Designer Cells AGE1.CR as Candidates for MVA and Influenza Vaccine ProductionIn: ESACT - Proceedings of the 21st Annual meeting of the European Society for animal cell technology (ESACT), 615–631doi: 10.1007/978-94-007-0884-6_102.

Genzel, Y., Lohr, V., Behrendt, I., Scharfenberg, K., Kamen, A., Schiedner, G., Jordan, I., & Reichl, U.Cell culture-based influenza virus production: suspension or adherent producer cell lines?Presented at: Cell line development and engineering 2012Cologne, Germany, February 13, 2012.

Genzel, Y., Janke, R., Isken, B., Rödig, J., Rapp, E., Lohr, V., Behrendt, I., Scharfenberg, K., Kamen, A., Schiedner, G., Jordan, I., & Reichl, U.Influenza virus production: characteristics of different producer cell linesPresented at: 10th PEACe 2011Cascais, Portugal, September 25, 2011.

Lohr, V., Genzel, Y., Jordan, I., Sandig, V., & Reichl, U.Stoffwechsel und Zellphysiologie aviärer Designerzellen während Wachstum und MVA-ProduktionPresented at: ProcessNet-Jahrestagung 2009 und 27. Jahrestagung der BiotechnologenMannheim, Germany, September 8, 2009.

Lohr, V., Rath, A., Jordan, I., Sandig, V., Genzel, Y., & Reichl, U.Avian designer cells AGE1.CR: possible candidates for MVA and influenza vaccine production?Presented at: 21st ESACT MeetingDublin, Ireland, June 7, 2009.

Rath, A., Lohr, V., Genzel, Y., Schwarzer, J., Rapp, E., Sandig, V., Jordan, I., & Reichl, U.Influenza and modified vaccinia Ankara (MVA) production in avian designer cellsPresented at: BioperspectivesHannover, Germany, October 9, 2008.

Tapia, F., Vazquez-Ramirez, D., Lohr, V., Genzel, Y., Jordan, I., Sandig, V., & Reichl, U.A flow cytometry-based assay for quantification of infectious influenza and vaccinia virionsPresented at: Vaccine Technology 2014Playa del Carmen, Mexico, June 8, 2014.

von Stosch, M., Vazquez-Ramirez, D., Lohr, V., de Azevedo, C., Luis, M., Genzel, Y., Reichl, U., & Oliveira, R.Towards effective media composition & process control optimization for high cell density cellbased virus productionPresented at: ESBES - 10th European Symposium on Biochemical Engineering SciencesLille, France, September 7, 2014.

Vázquez-Ramirez, D., Lohr, V., Díaz Mirón, J. E. Z., Genzel, Y., & Reichl, U.Development of a flow cytometry-based assay for the quantification of infectious influenza virionsPresented at: 23rd ESACT Meeting Lille, France, June 23, 2013.

Lohr, V., Blechert, A.-K., Genzel, Y., Jordan, I., & Reichl, U.Characterization of AGE1.CR.pIX high cell density cultivations for vaccinia virus productionPresented at: GVC/DECHEMA Vortrags- und Diskussionstagung Biopharmazeutische ProduktionFreiburg, Germany, May 14, 2012.

Lohr, V., Genzel, Y., Katinger, D., Jordan, I., Sandig, V., & Reichl, U.Live attenuated influenza virus production in batch high cell density cultivation of suspension AGE1.CR.pIX cellsPresented at: Vaccine Technology IVAlbufeira, Portugal, May 20, 2012.

Lohr, V., Haedicke, O., Genzel, Y., Jordan, I., Sandig, V., & Reichl, U.Comparative metabolic flux analyses of cultivations with novel avian designer cell lines used for vaccine productionPresented at: Cell Culture Engineering XIIIScottsdale, Arizona, USA, April 22, 2012.